Found: 58
Select item for more details and to access through your institution.
Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care.
- Published in:
- International Journal of Hematology, 2012, v. 96, n. 1, p. 26, doi. 10.1007/s12185-012-1088-8
- By:
- Publication type:
- Article
Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2005, v. 43, n. 2, p. 133, doi. 10.1515/CCLM.2005.022
- By:
- Publication type:
- Article
Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 114, doi. 10.1111/bjh.18163
- By:
- Publication type:
- Article
CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 2, p. 210, doi. 10.1111/bjh.13563
- By:
- Publication type:
- Article
Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 3, p. 337, doi. 10.1111/bjh.13037
- By:
- Publication type:
- Article
Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 1, doi. 10.1111/bjh.13037
- By:
- Publication type:
- Article
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 11, p. 547, doi. 10.1002/gcc.22667
- By:
- Publication type:
- Article
The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts.
- Published in:
- PLoS ONE, 2008, v. 3, n. 4, p. 1, doi. 10.1371/journal.pone.0001970
- By:
- Publication type:
- Article
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2741, doi. 10.1007/s00277-023-05394-0
- By:
- Publication type:
- Article
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Causes of death in 2877 patients with myelodysplastic syndromes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 1, doi. 10.1007/s00277-013-1863-5
- By:
- Publication type:
- Article
A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Immunthrombozytopenie - Onkopedia-Leitlinien Update: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH + SSH und GPOH.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, p. 6, doi. 10.1159/000356910
- By:
- Publication type:
- Article
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation—Results from the LenaMain Trial (NCT00891384).
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5157, doi. 10.3390/cancers15215157
- By:
- Publication type:
- Article
Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8386, doi. 10.1002/cam4.3448
- By:
- Publication type:
- Article
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refracty acute myeloid leukemia in a randomized phase II study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider.
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 2, p. 169, doi. 10.1111/ejh.12415
- By:
- Publication type:
- Article
Outcomes in RBC transfusion-dependent patients with Low-/ Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 5, p. 429, doi. 10.1111/ejh.12380
- By:
- Publication type:
- Article
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 5, p. 423, doi. 10.1111/ejh.12181
- By:
- Publication type:
- Article
Improved prophylaxis against overwhelming postsplenectomy infections.
- Published in:
- European Journal of Haematology, 1997, v. 59, n. 5, p. 329, doi. 10.1111/j.1600-0609.1997.tb01695.x
- By:
- Publication type:
- Article
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high‐risk karyotypes.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 2, p. 345, doi. 10.1002/cncr.22779
- By:
- Publication type:
- Article
Imatinib Compared With Chemotherapy as Front-Line Treatment of Elderly Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL).
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 10, p. 2068, doi. 10.1002/cncr.22631
- By:
- Publication type:
- Article
Evaluation of Neutropenic Fever: Value of Serum and Plasma Parameters in Clinical Practice.
- Published in:
- Chemotherapy (0009-3157), 2000, v. 46, n. 2, p. 77, doi. 10.1159/000007259
- By:
- Publication type:
- Article
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.
- Published in:
- Nature Communications, 2015, v. 6, n. 1, p. 5901, doi. 10.1038/ncomms6901
- By:
- Publication type:
- Article
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e874, doi. 10.1016/j.clml.2022.05.001
- By:
- Publication type:
- Article
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 9, p. 841, doi. 10.1007/s00277-010-1015-0
- By:
- Publication type:
- Article
Reduction of 5-azacitidine induced skin reactions in MDS patients with evening primrose oil.
- Published in:
- 2010
- By:
- Publication type:
- randomized controlled trial
Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 4, p. 365, doi. 10.1007/s00277-009-0846-z
- By:
- Publication type:
- Article
Meeting report: Vienna 2008 Workshop of the German–Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
- Published in:
- Annals of Hematology, 2009, v. 88, n. 7, p. 607, doi. 10.1007/s00277-008-0673-7
- By:
- Publication type:
- Article
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes.
- Published in:
- Annals of Hematology, 2008, v. 87, n. 5, p. 345, doi. 10.1007/s00277-008-0449-0
- By:
- Publication type:
- Article
Lenalidomide in the context of complex karyotype or interrupted treatment: case reviews of del(5q)MDS patients with unexpected responses.
- Published in:
- Annals of Hematology, 2007, v. 86, n. 2, p. 133, doi. 10.1007/s00277-006-0217-y
- By:
- Publication type:
- Article
Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-a: a phase II study.
- Published in:
- Annals of Hematology, 2005, v. 84, n. 6, p. 389, doi. 10.1007/s00277-005-1027-3
- By:
- Publication type:
- Article
Concomitant Non-Small Cell Lung Cancer and Hairy Cell Leukemia in a Patient Harboring BRAF-V600E Mutation in Both Tissues: A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 12, p. 809, doi. 10.1002/gcc.22292
- By:
- Publication type:
- Article
Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 5, p. 558, doi. 10.1002/ajh.23163
- By:
- Publication type:
- Article
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0491-2
- By:
- Publication type:
- Article
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1838, doi. 10.1002/cncr.28663
- By:
- Publication type:
- Article
Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 14, p. 2611, doi. 10.1002/cncr.28113
- By:
- Publication type:
- Article
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 2, p. 272, doi. 10.1111/j.1365-2141.2011.08672.x
- By:
- Publication type:
- Article
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 1, p. 86, doi. 10.1111/j.1365-2141.2009.07720.x
- By:
- Publication type:
- Article
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 1, p. 57, doi. 10.1111/j.1365-2141.2008.07178.x
- By:
- Publication type:
- Article